CEACAM5 and cancer: Prostate-specific antigen (PSA)-, α-fetoprotein (AFP)-, carcinoembryonic antigen (CEA)-, or other cancer type-specific promoters induce efficient therapeutic gene expression in a cancer cell-specific manner9–12.